Severe osteoporosis treatment: anabolic therapy options
https://doi.org/10.37586/2686-8636-2-2021-226-230
Abstract
The world's population is aging rapidly, with increasing prevalence of many chronic diseases that are more common in older people. Osteopenia and osteoporosis are two chronic conditions often diagnosed in frail older patients, and both seem to be a significant public health burden. In Russia, osteoporosis (in accordance with the criteria of the World Health Organization) was detected in 33.8% of women and 26.9% of men aged 50 and over. Every minute in the country, 7 vertebral fractures happen, and every 5 minutes — a fracture of the proximal femur occurs. According to the latest data, about 34 million people in Russia are at high risk of developing low-energy fractures. The use of anabolic therapy in older patients with severe osteoporosis can achieve optimal results in the accumulation of bone mineral density and significantly reduce the risk of repeated low-energy fractures.
About the Authors
L. V. Matchekhina
Pirogov Russian National Research Medical University, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
Matchekhina Lubov V. - MD, PhD, research fellow, laboratory of age-related endocrine and metabolic disorders, Pirogov National Research Medical University, Russian Gerontology Research and Clinical Centre.
Moscow.
eLibrary SPIN: 6453-5835
E. N. Dudinskaya
Pirogov Russian National Research Medical University, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
Dudinskaya Ekaterina N. - MD, PhD, Head of age-related endocrine and metabolic disorders laboratory, Pirogov National Research Medical University, Russian Gerontology Research and Clinical Centre.
Moscow.
Tel.: +7(903)191-46-90
O. N. Tkacheva
Pirogov Russian National Research Medical University, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
Tkacheva Olga N. - MD, PhD, professor, Director, Pirogov National Research Medical University, Russian Gerontology Research and Clinical Centre.
Moscow.
Tel.: +7(499) 187-64-67
N. O. Khovasova
Pirogov Russian National Research Medical University, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
Khovasova Natalia O. - MD, PhD, associate professor, Age-related diseases Department, Pirogov National Research Medical University, senior research fellow, Laboratory of musculoskeletal diseases, Pirogov National Research Medical University, Russian Gerontology Research and Clinical Centre.
Moscow.
Tel.: +7(915)004-43-00
References
1. Wright N.C., Looker A., Saag K., Curtis Jr., Dalzell E.S., Randall S., Dawson-Hughes B. The recent prevalence of osteoporosis and low bone mass based on bone mineral density at the femoral neck or lumbar spine in the United States. J bone miner res. 2014: 29(11): 2520-2526.
2. Amin S., Achenbach S.J., Atkinson E.J., Khosla S., Melton L.J. Trends in fracture incidence: a population-based study over 20 years. J bone miner res. 2014: 29: 581-589.
3. Cooper C., Campion G., Melton L.J. (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2: 285-289.
4. Evstigneeva LP. Non-drug methods of treatment of osteoporosis. Almanac of clinical medicine. 2014; (32): 73-79 (in Russ.).
5. Bulletin of Rosstat «Estimated population of the Russian Federation until 2035» (electronic resource). URL: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/demography/ access date: 07.02.2019 (in Russ.).
6. Ershov VE, Rodionova SS, Krivova AV, Zakharov VP. Demographic trends in dealing with osteoporosis and its consequences. RMJ. 2019; 4: 11-14 (in Russ.).
7. Obermayer-Pietsch B.M., Marin F., McCloskey E.V., Hadji P., Farrerons J., Boonen S., Audran M., Barker C., Anastasilakis A.D., Fraser W.D., Nickelsen T. EUROFORS Investigators. Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J Bone Miner Res. 2008 Oct; 23(10): 1591-600. DOI: 10.1359/jbmr.080506.
8. Дудинская Е.Н., Браилова Н.В., Кузнецова В.А., Ткачева О.Н. Остеопороз у пожилых пациентов. Остеопороз и остеопатии. 2019; 22(3): 34-40. https://doi.org/10.14341/osteo12352.
9. Гребенникова Т.А., Белая Ж.Е., Мельниченко Г.А., Рожинская Л.Я., Цориев Т.Т., Дзеранова Л.К., Дедов И.И., Мамедова Е.О., Никанкина Л.В., Пигарова Е.А., Тарбаева Н.В., Чернова Т.О., Белова К.Ю., Бирюкова Е.В., Драпкина О.М., Древаль А.В., Ершова О.Б., Загородний Н.В., Крюкова И.В., Лесняк О.М., Марченкова Л.А., Никитинская О.А., Родионова С.С., Скрипникова И.А., Торопцова Н.В., Фарба Л.Я., Юренева С.В., Якушевская О.В., Дудинская Е.Н., Ткачева О.Н., Kanis J.A., Петряйкин А.В., Илюхина О.Б. Краткое изложение проекта федеральных клинических рекомендаций по остеопорозу. Остеопороз и остеопатии. 2020; 23(2): 4-21. https://doi.org/10.14341/osteo12373.
10. Minisola S., Cipriani C., Grotta G.D., et al. Update on the safety and efficacy of teriparatide in the treatment of osteoporosis. Ther Adv Musculoskelet Dis. 2019; 11: 1759720X19877994. Published 2019 Oct 5. DOI: 10.1177/1759720X19877994.
11. Leder B.Z., Tsai J.N., Uihlein A.V., Wallace P.M., Lee H., Neer R.M., Burnett-Bowie S.A. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet. 2015 Sep 19; 386(9999): 1147-55. DOI: 10.1016/S0140-6736(15)61120-5. Epub 2015 Jul 2. PMID: 26144908; PMCID: PMC4620731.
12. Браилова Н.В., Кузнецова В.А., Дудинская Е.Н., Ткачева О.Н. Старение костной ткани. Российский журнал гериатрической медицины. 2020; 2: 147-153. https://doi.org/10.37586/2686-8636-2-2020-147-153.
13. Grebennikova T.A., Belaya Z.E. Trabecular bone score for the diagnostics of osteoporosis in subjects with type 2 diabetes mellitus: a clinical case. Osteoporosis and Bone Diseases. 2017; 20(1): 22-27 (in Russ.)]. https://doi.org/10.14341/osteo2017139-43
Review
For citations:
Matchekhina L.V., Dudinskaya E.N., Tkacheva O.N., Khovasova N.O. Severe osteoporosis treatment: anabolic therapy options. Russian Journal of Geriatric Medicine. 2021;(2):236-240. (In Russ.) https://doi.org/10.37586/2686-8636-2-2021-226-230
Views:
508
Email this article 